🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Usana Health Sciences director sells shares worth over $21k

Published 07/05/2024, 21:16
USNA
-

In a recent transaction on May 7, Gilbert A. Fuller, a director at USANA Health (NYSE:USNA) Sciences Inc. (NYSE:USNA), sold 490 shares of the company's common stock. The sale was executed at a weighted average price of $44.589, with the transaction totaling over $21,848.

Investors following USANA Health Sciences may note that the price range for these transactions varied slightly, with shares being sold at prices between $44.572 and $44.63. This sale has brought Fuller's ownership in the company down to zero shares, according to the latest filing.

USANA Health Sciences, based in Salt Lake City, Utah, operates in the medicinal chemicals and botanical products industry. The company's stock transactions are closely watched by investors who track insider selling and buying as indicators of confidence and potential future performance.

For those interested in the specifics of the company's stock movements, USANA Health Sciences trades under the ticker symbol NYSE:USNA. The company continues to be a subject of interest for those invested in the healthcare sector, particularly in the niche of nutritional products and supplements.

The details of this transaction are publicly available due to regulatory requirements, providing transparency into the trading activities of the company's directors and other insiders.

InvestingPro Insights

Following the recent insider transaction at USANA Health Sciences Inc . (NYSE:USNA), investors may find additional context through several key financial metrics and expert analysis. As of the latest data, USANA boasts an impressive gross profit margin of 80.98% over the last twelve months as of Q1 2024, reflecting a strong ability to control costs relative to revenue.

The company's valuation also presents an interesting picture, with a Price/Earnings (P/E) ratio of 13.87, and an adjusted P/E ratio for the same period standing at 13.95. This suggests that USANA's stock is trading at a low earnings multiple, which could be attractive to value-oriented investors.

Investors may also be reassured by USANA's financial stability, as the company holds more cash than debt on its balance sheet, providing a cushion against market volatility and unforeseen expenses.

For those considering a deeper dive into USANA's financial health and market potential, InvestingPro offers additional insights. In total, there are 9 InvestingPro Tips available, which include perspectives on earnings revisions by analysts and the company's ability to cover interest payments with its cash flows. These insights can be accessed by visiting https://www.investing.com/pro/USNA, and readers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, offering a more comprehensive understanding of USANA's investment profile.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.